PRESS RELEASE published on 01/17/2024 at 12:00, 2 years 4 months ago UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com. UTILITY Therapeutics PIVYA Urinary Tract Infections Antibiotic FDA Approval
Published on 05/25/2026 at 13:30, 7 hours 5 minutes ago ZTEST Electronics Inc. Announces Fiscal 2026 Q3 Results with 13.9% Year Over Year Revenue Growth
Published on 05/25/2026 at 13:30, 7 hours 5 minutes ago ESgold Corp. Engages ICP Securities for Automated Market Making Services
Published on 05/23/2026 at 03:15, 2 days 17 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 2 days 17 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/25/2026 at 18:45, 1 hour 50 minutes ago 'Made in Binzhou' Heads to Tianzhou-10 Cargo Spacecraft——Binzhou Sci-Tech Power Embarks on a Hardcore Space Mission
Published on 05/25/2026 at 18:00, 2 hours 35 minutes ago Huawei Hosts 3rd Global C&I Visionaries Summit, Shaping a Greener Future Across Diverse Industries
Published on 05/25/2026 at 17:00, 3 hours 35 minutes ago TCMA x Chulalongkorn University Join Forces with Canadian Partners to Advance Strategic Collaboration for a Low-Carbon Industry toward Net Zero 2050
Published on 05/25/2026 at 16:31, 4 hours 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle PLC
Published on 05/25/2026 at 16:30, 4 hours 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 05/22/2026 at 18:05, 3 days 2 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 3 days 7 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 3 days 12 hours ago Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco